Internal Medicine · Lake Charles, LA
NPI
1669448080
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
2770 3rd Ave Ste 300
Lake Charles, LA, 70601
Phone (337) 494-6800
Groups this clinician bills Medicare through
Medicare paid, 2024
$337K
7,165 services
Medicare patients, 2024
453
Average age 78
Drug cost, 2024
$1.7M
20,541 prescriptions
Company payments, 2025
$104
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mir A Khan was code 99309 (snf e&m), 1,389 times for 111 patients. In total Mir A Khan billed 7,165 services in 50 codes, and Medicare paid $337K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Facility | 1,389 | 111 | $79.40 | $110K |
| 99309 SNF E&M | Office | 898 | 173 | $76.82 | $69K |
| 99233 Hospital E&M - Subsequent | Facility | 546 | 129 | $88.39 | $48K |
| 99214 Office E&M - Established | Office | 274 | 158 | $77.37 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 246 | 149 | $10.79 | $2,656 |
| 99239 Hospital Discharge Management | Facility | 112 | 81 | $85.07 | $9,528 |
| 99223 Hospital E&M - Initial | Facility | 108 | 86 | $127.00 | $14K |
| 99310 SNF E&M | Office | 97 | 52 | $113.73 | $11K |
| 99306 SNF E&M | Facility | 74 | 57 | $135.67 | $10K |
| 99291 Critical Care E&M | Facility | 66 | 27 | $159.56 | $11K |
| 99306 SNF E&M | Office | 62 | 50 | $134.44 | $8,335 |
| 96372 Injection Administration | Office | 46 | 26 | $9.11 | $419 |
| 99310 SNF E&M | Facility | 33 | 27 | $114.29 | $3,772 |
| G0008 Administration of influenza virus vaccine | Office | 31 | 31 | $30.16 | $935 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 26 | 12 | $29.23 | $760 |
By year: 2022 $228K for 10,222 services; 2023 $257K for 13,788 services; 2024 $337K for 7,165 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mir A Khan prescribed most often to Medicare patients was Levothyroxine Sodium, with 828 prescriptions and refills. In total Mir A Khan wrote 20,541 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 828 | 1,247 | 123 | $7,235 |
| Pantoprazole Sodium Generic | 707 | 961 | 125 | $13K |
| Atorvastatin Calcium Generic | 646 | 831 | 106 | $6,860 |
| Eliquis Apixaban | 473 | 493 | 43 | $167K |
| Gabapentin Generic | 473 | 588 | 79 | $5,358 |
| Amlodipine Besylate Generic | 441 | 638 | 88 | $2,904 |
| Sertraline Hcl Generic | 408 | 473 | 53 | $4,452 |
| Furosemide Generic | 362 | 432 | 68 | $2,096 |
| Alprazolam Generic | 359 | 374 | 59 | $2,577 |
| Metoprolol Tartrate Generic | 347 | 453 | 63 | $3,025 |
| Tamsulosin Hcl Generic | 335 | 412 | 49 | $4,434 |
| Potassium Chloride Generic | 297 | 413 | 60 | $5,556 |
| Trazodone Hcl Generic | 293 | 347 | 55 | $2,592 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 280 | 281 | 59 | $5,143 |
| Lisinopril Generic | 267 | 361 | 50 | $2,123 |
Brand drugs: 3,253 claims; generic drugs: 17,231 claims; opioid claims: 626.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mir A Khan $104 ($104 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbvie Inc. with $37.9.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.